Research

Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 12/11/2019 9:14:22 PM
RT @ExosomeRNA: Her work on #mesenchymalstromalcells and their secreted #extracellularvesicles/ #exosomes as vectors of #intercellularsigna…
BCH Innovation News @BCH_Innovation 12/11/2019 9:14:15 PM
RT @ASGCTherapy: An ex vivo #CellTherapy to treat #SickleCell disease was safe and showed strong signs of durable efficacy in phase 1 study…
BCH Innovation News @BCH_Innovation 12/11/2019 9:14:01 PM
RT @DFBC_PedCare: .@BioWorld reports on recent sickle cell research presented by @BostonChildrens researchers at #ASH19. https://t.co/EjPcM…
BCH Innovation News @BCH_Innovation 12/11/2019 8:00:00 PM
In a presentation at #ASH19, Boston Children’s Dr. Erica Esrick shared findings from a phase I study in which a new… https://t.co/SEeOW0RdQa
BCH Innovation News @BCH_Innovation 12/11/2019 7:30:00 PM
NPR's @MorningEdition discussed recent progress using #genetherapy to treat #sicklecell disease, mentioning that Bo… https://t.co/L06iN8HNkg
BCH Innovation News @BCH_Innovation 12/11/2019 3:00:01 PM
Two new #genes that cause the development of a rare form of #epilepsy have been identified: https://t.co/UwzsYYARUx via @medical_xpress
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer